ArticleBMJ open2026

Tirzepatide safety in EudraVigilance: descriptive and disproportionality analysis of preferred terms related to suboptimal treatment outcomes and drug-use-related issues.

Ioana Rada Popa Ilie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.